Donald T. Pals

1.7k total citations
45 papers, 1.3k citations indexed

About

Donald T. Pals is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Donald T. Pals has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 7 papers in Physiology. Recurrent topics in Donald T. Pals's work include Renin-Angiotensin System Studies (17 papers), Receptor Mechanisms and Signaling (13 papers) and Chemical Synthesis and Analysis (7 papers). Donald T. Pals is often cited by papers focused on Renin-Angiotensin System Studies (17 papers), Receptor Mechanisms and Signaling (13 papers) and Chemical Synthesis and Analysis (7 papers). Donald T. Pals collaborates with scholars based in United States, United Kingdom and Japan. Donald T. Pals's co-authors include Suvit Thaisrivongs, F. D. Masucci, George S. Denning, Steve R. Turner, Dyral C. Fessler, Warren M. Kati, Lisa M. Thomasco, Douglas W. Harris, S.R. Turner and Judy A. Lawson and has published in prestigious journals such as Nature, Circulation Research and Biochemistry.

In The Last Decade

Donald T. Pals

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald T. Pals United States 18 690 435 388 174 156 45 1.3k
Robert R. Smeby United States 25 1.1k 1.5× 735 1.7× 229 0.6× 418 2.4× 186 1.2× 70 1.9k
Dino Nisato France 24 857 1.2× 761 1.7× 367 0.9× 159 0.9× 239 1.5× 77 2.2k
B. Kamber Switzerland 25 1.7k 2.4× 761 1.7× 592 1.5× 424 2.4× 344 2.2× 50 2.3k
Joachim Mittendorf Germany 18 584 0.8× 327 0.8× 435 1.1× 179 1.0× 91 0.6× 29 1.4k
Robert Ardecky United States 22 1.3k 1.8× 841 1.9× 315 0.8× 479 2.8× 343 2.2× 41 2.0k
Kenneth E.J. Dickinson United States 22 845 1.2× 325 0.7× 208 0.5× 155 0.9× 456 2.9× 61 1.5k
Robert J. DeVita United States 26 770 1.1× 95 0.2× 576 1.5× 280 1.6× 64 0.4× 71 1.8k
Toichi Takenaka Japan 25 781 1.1× 356 0.8× 237 0.6× 176 1.0× 234 1.5× 106 1.8k
Ronald P. Frigon United States 21 833 1.2× 171 0.4× 161 0.4× 188 1.1× 170 1.1× 38 1.8k
Brian D. Dayton United States 22 650 0.9× 211 0.5× 244 0.6× 100 0.6× 119 0.8× 38 1.5k

Countries citing papers authored by Donald T. Pals

Since Specialization
Citations

This map shows the geographic impact of Donald T. Pals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald T. Pals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald T. Pals more than expected).

Fields of papers citing papers by Donald T. Pals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald T. Pals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald T. Pals. The network helps show where Donald T. Pals may publish in the future.

Co-authorship network of co-authors of Donald T. Pals

This figure shows the co-authorship network connecting the top 25 collaborators of Donald T. Pals. A scholar is included among the top collaborators of Donald T. Pals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald T. Pals. Donald T. Pals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pals, Donald T., et al.. (1993). Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 6–10. 18 indexed citations
2.
Pals, Donald T., et al.. (1993). Renin Release Induced by Losartan (DuP 753), an Angiotensin II Receptor Antagonist. Clinical and Experimental Hypertension. 15(1). 1–13. 17 indexed citations
3.
Pals, Donald T., et al.. (1991). Additive Combination Studies of Captopril and Ditekiren, a Renin Inhibitor, in Nonhuman Primates. Clinical and Experimental Hypertension Part A Theory and Practice. 13(3). 425–436. 4 indexed citations
4.
5.
Pals, Donald T., et al.. (1990). Rat model for evaluating inhibitors of human renin. Journal of Pharmacological Methods. 23(4). 239–245. 9 indexed citations
6.
Thaisrivongs, Suvit, et al.. (1990). Renin inhibitory peptides. A .beta.-aspartyl residue as a replacement for the histidyl residue at the P-2 site. Journal of Medicinal Chemistry. 33(5). 1337–1343. 7 indexed citations
7.
Thaisrivongs, Suvit, et al.. (1989). Renin inhibitory peptides: a study of structural modifications in the peptide backbone. Journal of Hypertension. 7(2). S21–S23. 9 indexed citations
8.
Pals, Donald T., et al.. (1988). Renin inhibitors containing .psi.[CH2O] pseudopeptide inserts. Journal of Medicinal Chemistry. 31(3). 671–677. 29 indexed citations
9.
Thaisrivongs, Suvit, et al.. (1988). Conformationally constrained renin inhibitory peptides: .gamma.-lactam-bridged dipeptide isostere as conformational restriction. Journal of Medicinal Chemistry. 31(7). 1369–1376. 50 indexed citations
10.
Smith, Clark W., Hossain Saneii, Tomi K. Sawyer, et al.. (1988). Synthesis and renin inhibitory activity of angiotensinogen analogs having dehydrostatine, Lue.psi.[CH2S]Val, or Lue.psi.[CH2SO] Val at the Pt, P1' cleavage site. Journal of Medicinal Chemistry. 31(7). 1377–1382. 7 indexed citations
11.
Thaisrivongs, Suvit, Heinrich J. Schostarez, Donald T. Pals, & S.R. Turner. (1987). .alpha.,.alpha.-Difluoro-.beta.-aminodeoxystatine-containing renin-inhibitory peptides. Journal of Medicinal Chemistry. 30(10). 1837–1842. 71 indexed citations
12.
Pals, Donald T., et al.. (1985). Cardiovascular Effects of a Renin Inhibitor in Relation to Posture in Nonhuman Primates. Clinical and Experimental Hypertension Part A Theory and Practice. 7(1). 105–121. 4 indexed citations
13.
Thaisrivongs, Suvit, Donald T. Pals, Warren M. Kati, Steve R. Turner, & Lisa M. Thomasco. (1985). Difluorostatine and difluorostatone containing peptides as potent and specific renin inhibitors. Journal of Medicinal Chemistry. 28(11). 1553–1555. 55 indexed citations
14.
Pals, Donald T., et al.. (1985). Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.. Journal of Pharmacology and Experimental Therapeutics. 232(2). 407–412. 4 indexed citations
15.
Pals, Donald T., et al.. (1981). Participation of prostaglandins in the vasodepressor effect of substance P. Journal of Pharmacy and Pharmacology. 33(1). 110–111. 7 indexed citations
16.
Pals, Donald T., et al.. (1980). Evidence against prostaglandin modulation of cardioaccelerator nerve activity in the anesthetized dog. Prostaglandins. 20(1). 147–152. 6 indexed citations
17.
Fessler, Dyral C., et al.. (1972). Angiotensin II antagonism. Structure-activity relations of 8-substituted angiotensin II analogs. Journal of Medicinal Chemistry. 15(10). 1015–1016. 3 indexed citations
18.
Pals, Donald T., et al.. (1971). Role of the Pressor Action of Angiotensin IIin Experimental Hypertension. Circulation Research. 29(6). 673–681. 240 indexed citations
19.
Pals, Donald T.. (1968). Effect of bretylium tosylate on angiotensin pressor responses in the pithed rat.. PubMed. 173(2). 417–25. 2 indexed citations
20.
Halliday, Robert P., et al.. (1968). Allenic Amines: A New Class of Nonhydrazine MAO Inhibitors. Journal of Pharmaceutical Sciences. 57(3). 430–433. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert R. Smeby Breakdown of academic impact, for papers by Dino Nisato Breakdown of academic impact, for papers by B. Kamber Breakdown of academic impact, for papers by Joachim Mittendorf Breakdown of academic impact, for papers by Robert Ardecky Breakdown of academic impact, for papers by Kenneth E.J. Dickinson Breakdown of academic impact, for papers by Robert J. DeVita Breakdown of academic impact, for papers by Toichi Takenaka Breakdown of academic impact, for papers by Ronald P. Frigon Breakdown of academic impact, for papers by Brian D. Dayton
Rankless by CCL
2026